|
64
|
227
|
2h8mA |
N-domain of grp94 in complex with the 2-iodo-neca |
|
65
|
236
|
2hchA |
N-domain of grp94 in complex with the novel ligand n-(2-amino)ethyl carboxyamido adenosine |
|
65
|
236
|
2gqpA |
N-domain of grp94 in complex with the novel ligand n-propyl carboxyamido adenosine |
|
66
|
209
|
2h55A |
Structure of human hsp90-alpha bound to the potent water soluble inhibitor pu-dz8 |
|
69
|
227
|
2gfdA |
Grp94 in complex with the novel hsp90 inhibitor radamide |
|
69
|
207
|
2fwyA |
Structure of human hsp90-alpha bound to the potent water soluble inhibitor pu-h64 |
|
69
|
213
|
2fxsA |
Yeast hsp82 in complex with the novel hsp90 inhibitor radamide |
|
65
|
236
|
2fypA |
Grp94 in complex with the novel hsp90 inhibitor radester amine |
|
68
|
181
|
2ftkA |
Berylloflouride spo0f complex with spo0b |
|
67
|
208
|
2fwzA |
Structure of human hsp90-alpha bound to the potent water soluble inhibitor pu-h71 |
|
63
|
229
|
2exlA |
Grp94 n-terminal domain bound to geldanamycin |
|
75
|
227
|
2esaA |
Grp94 n-terminal domain bound to geldanamycin: effects of mutants 168-169 ks-aa |
|
123
|
367
|
2e0aA |
Crystal structure of human pyruvate dehydrogenase kinase 4 in complex with amppnp |
|
55
|
208
|
2ccuA |
Human hsp90 with 4-chloro-6-(4-(4-(4-methanesulphonyl-benzyl)- pierazin-1-yl)-1h-pyrazol-3-yl)-benzene-1,3-diol |
|
71
|
212
|
2cgfA |
A radicicol analogue bound to the atp binding site of the n-terminal domain of the yeast hsp90 chaperone |
|
131
|
676
|
2cg9A |
Crystal structure of an hsp90-sba1 closed chaperone complex |
|
63
|
208
|
2cctA |
Human hsp90 with 5-(5-chloro-2,4-dihydroxy-phenyl)-4-piperazin-1-yl- 2h-pyrazole-3-carboxylic acid ethylamide |
|
67
|
210
|
2bz5A |
Structure-based discovery of a new class of hsp90 inhibitors |
|
68
|
208
|
2ccsA |
Human hsp90 with 4-chloro-6-(4-piperazin-1-yl-1h-pyrazol-3-yl)- benzene-1,2-diol |
|
72
|
320
|
2ch4A |
Complex between bacterial chemotaxis histidine kinase chea domains p4 and p5 and receptor-adaptor protein chew |
|
133
|
418
|
2c1gA |
Structure of streptococcus pneumoniae peptidoglycan deacetylase (sppgda) |
|
68
|
215
|
2byhA |
3-(5-chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the hsp90 molecular chaperone |
|
138
|
418
|
2c1iA |
Structure of streptococcus pneumoniae peptidoglycan deacetylase (sppgda) d 275 n mutant. |
|
68
|
215
|
2byiA |
3-(5-chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the hsp90 molecular chaperone |
|
81
|
249
|
2c2aA |
Structure of the entire cytoplasmic portion of a sensor histidine kinase protein |
|
66
|
208
|
2bt0A |
Novel, potent small molecule inhibitors of the molecular chaperone hsp90 discovered through structure-based design |
|
124
|
370
|
2bu8A |
Crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands |
|
66
|
208
|
2bsmA |
Novel, potent small molecule inhibitors of the molecular chaperone hsp90 discovered through structure-based design |
|
120
|
379
|
2bu5A |
Crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands |
|
131
|
379
|
2bu7A |
Crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands |
|
126
|
379
|
2bu2A |
Crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands |
|
71
|
212
|
2breA |
Structure of a hsp90 inhibitor bound to the n-terminus of yeast hsp90. |
|
125
|
379
|
2bu6A |
Crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands |
|
72
|
214
|
2brcA |
Structure of a hsp90 inhibitor bound to the n-terminus of yeast hsp90. |
|
124
|
379
|
2btzA |
Crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands |
|
56
|
184
|
2akpA |
Hsp90 delta24-n210 mutant |
|
63
|
213
|
1zw9A |
Yeast hsp82 in complex with the novel hsp90 inhibitor 8-(6-bromo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)-adenine |
|
101
|
394
|
1zxnA |
Human dna topoisomerase iia atpase/adp |
|
73
|
213
|
1zwhA |
Yeast hsp82 in complex with the novel hsp90 inhibitor radester amine |
|
125
|
377
|
1zxmA |
Human topo iia atpase/amp-pnp |
|
149
|
466
|
1z5bA |
Topoisomerase vi-b, adp alf4- bound dimer form |
|
140
|
462
|
1z59A |
Topoisomerase vi-b, adp-bound monomer form |
|
154
|
466
|
1z5aA |
Topoisomerase vi-b, adp-bound dimer form |
|
71
|
236
|
1yt1A |
Crystal structure of the unliganded form of grp94, the er hsp90: basis for nucleotide-induced conformational change, grp94n(delta)41 apo crystal |
|
140
|
466
|
1z5cA |
Topoisomerase vi-b, adp pi bound dimer form |
|
57
|
227
|
1yt0A |
Crystal structure of the unliganded form of grp94, the er hsp90: basis for nucleotide-induced conformational change, grp94n(delta)41 apo crystal soaked with adp |
|
67
|
213
|
1yetA |
Geldanamycin bound to the hsp90 geldanamycin-binding domain |
|
67
|
210
|
1yc1A |
Crystal structures of human hsp90alpha complexed with dihydroxyphenylpyrazoles |
|
69
|
210
|
1yc4A |
Crystal structure of human hsp90alpha complexed with dihydroxyphenylpyrazoles |
|
70
|
207
|
1yerA |
Human hsp90 geldanamycin-binding domain, "closed" conformation |
